利用吸入的纳米颗粒来克服呼吸道疾病治疗的肺障碍
Zhaokui Jin1, Qi Gao1, Keke Wu1
1School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, PR China.
Advanced drug delivery reviews
|October 11, 2023
概括
吸入纳米药物提供了一个有希望的解决方案,通过克服肺障碍来治疗肺部疾病. 本综述探讨了使用纳米医学的有效和安全的肺部药物输送的挑战和策略.
科学领域:
- 肺部医学 肺部医学
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 由于无效的治疗方法,肺部疾病对全球健康造成了重大负担.
- 肺屏障是传统药物输送到肺部的主要障碍.
- 吸入纳米药物提供了一个潜在的解决方案,用于局部和精确的药物输送到肺病理.
研究的目的:
- 审查肺部药物输送障碍以及纳米医学在克服这些障碍方面的作用.
- 讨论吸入纳米药物的物理化学特性和配方策略.
- 为合理设计和肺纳米治疗药物的临床应用提供指导.
主要方法:
- 关于肺部疾病,药物输送障碍和纳米医学的文献综述.
- 对纳米载体的物理化学特性和配方策略的分析.
- 对肺部应用纳米医药设计优势的评估.
主要成果:
- 确定了关键的肺输送障碍和影响它们的因素.
- 强调纳米医学在提高药物输送效率和安全方面的潜力.
- 讨论了各种纳米载体和用于肺部药物输送的配方策略.
结论:
- 纳米医学在改善呼吸道疾病的吸入药物输送方面具有重大前景.
- 克服肺部障碍需要仔细考虑纳米载体的设计和配方.
- 需要进一步的研究和临床转化来实现肺纳米疗法的全部潜力.
相关概念视频
Inhaled Medications
292
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
292
Drugs Used in Lower Respiratory Disorders: Overview
462
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
462
Drug Delivery: Miscellaneous Routes
361
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
361
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
236
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
236
Additional Routes of Drug Administration
2.8K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
2.8K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
192
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
192


